Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-04-10
1999-11-16
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544233, 544340, A01N 4358, C07D23726, C07D24136
Patent
active
059858761
ABSTRACT:
Five new nucleophile substituted ecteinascidin (Et) compounds have been isolated from extracts of Ecteinascidia turbinata. These compounds have been purified by chromatographic techniques and their structures and bioactivities have been determined. The five nucleophile substituted Et compounds have been designated herein as Et 802 (1), Et 788 (2), Et 760 (3), Et 858 (4) and Et 815 (5). Also obtained were three new N-oxide ecteinascidin compounds, which have been designated herein as Et 717 (6), Et 775 (7) and Et 789 (8). Some of these newly discovered Et compounds show exceedingly potent cytotoxicity against L1210.
REFERENCES:
patent: 4273773 (1981-06-01), Demerson et al.
patent: 5089273 (1992-02-01), Rinehart et al.
patent: 5459141 (1995-10-01), Vertesy et al.
patent: 5484717 (1996-01-01), Zaccardi
Sakai et al., "Ecteinascidins: Putative Biosynthetic . . . ", J. Am. Chem. Soc., 1996, vol. 118, pp. 9017-9023.
Rinehart Kenneth L.
Zhou Tong
Linek Ernest V.
Shah Mukund J.
Truong Tamthom N.
LandOfFree
Nucleophile substituted ecteinascidins and N-oxide ecteinascidin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleophile substituted ecteinascidins and N-oxide ecteinascidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleophile substituted ecteinascidins and N-oxide ecteinascidin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325008